21 Dec, 2023 Our predictions for life sciences in 2024 By DLA Piper Life Sciences As the New Year is fast approaching, we asked members of our international Life Sciences team to share their predictions of what will be...
18 Dec, 2023 Transformative impact of Research and Development Block Exemptions By Richard Jenkinson Richard Jenkinson, a Senior Associate in our Competition Law Team, shares his insights on the transformative impact of Research and...
13 Dec, 2023 Experimental evidence in patent litigation – Rules for fair play By Rebecca Lawrence The technical nature of patent litigation means that experiments are often an essential (and sometimes the only) way to prove key aspects...
12 Dec, 2023 Uprooting Algorithmic Bias: How life sciences and healthcare organisations can minimise biased outcomes in the use of AI By Nicholas Tyacke Alex Horder Alexandra de Zwart Jordan Davis +1 more... Show less Artificial Intelligence (AI) is already altering the way we live and work, providing both opportunities to grow and challenges to...
08 Dec, 2023 Poland - Life Sciences Monthly Brief, November 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our November monthly briefing, which covers key updates and insights in the following areas: Medicinal...
06 Dec, 2023 New bill establishing rules for clinical trials with humans and instituting the National Ethics System governing clinical research - Brazil By Bruna Rocha Juliana Marcondes Victoria Cristofaro Last Wednesday 29 November, the Chamber of Deputies approved Bill No. 7082/2017 (in Portuguese, “Projeto de Lei n° 7082/2017”), which...
04 Dec, 2023 Vapes banned from January 2024 under Australian reforms By Greg Bodulovic Nicholas Tyacke Tudor Filaret Hazel Pang Shawn Wang +2 more... Show less The Australian Federal Government has announced the first stage of Australia’s vaping reforms, which are set to commence on 1 January...
23 Nov, 2023 UK CMA publishes Competition Law Guidance for Cooperations on Combination Therapies By Alexandra Kamerling Executive Summary Combination therapies involve the use of two or more separate medicines in combination to treat a disease. It can be...
22 Nov, 2023 Global Compliance Guide for Engaging Healthcare Professionals By Jolanta Dabrowicz Andrzej Balicki, Ph.D. Joanna Barker-Wall Pharmaceutical companies rely on the knowledge and expertise of healthcare professionals for purposes such as scientific discussions,...
17 Nov, 2023 UK Healthcare Procurement: Provider selection regime regulations overview By Sammi King Saman Anwar Mark Vipan It is currently intended that the Provider Selection Regime (PSR) will come into force on 1 January 2024. The PSR Regulations are a new...
15 Nov, 2023 Unscripted mishap: Australian telehealth provider fined for advertising prescription medicines By Greg Bodulovic Nicholas Tyacke Tudor Filaret Hazel Pang +1 more... Show less The Therapeutic Goods Administration (TGA) has fined InstantScripts, a major Australian telehealth service provider, $742,500 for alleged...
13 Nov, 2023 Poland Life Sciences Monthly Brief, October 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our October monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
10 Nov, 2023 Implementation Rules of Human Genetic Resource Regulations—what it entails for life sciences clients in China By Ting Xiao Carolyn Bigg On June 1, 2023, China’s Ministry of Science and Technology (the “MOST”) issued the Implementation Rules of Administrative Regulations on...
06 Nov, 2023 The EU Foreign Subsidies Regulation - life sciences companies impacted by EC review of transactions and public procurement By Joost Haans Anna Sacco On 12 October 2023, EU Foreign Subsidies Regulation (“FSR”) filings to the European Commission (“EC”) became mandatory. In addition to...
01 Nov, 2023 AI Chatroom – conversational videos about the rapidly evolving legal landscape of AI By Kristi Kung Keo Shaw In this episode of DLA Piper’s video series AI ChatRoom, we focus on emerging issues in artificial intelligence and digital health. This...
25 Oct, 2023 Artificial Intelligence and healthcare: the Italian DPA adopts a decalogue on GDPR compliance of national healthcare services using AI By Cristina Criscuoli The use of artificial intelligence (‘AI’) systems in the pharmaceutical and healthcare sectors is growing exponentially, with...